| Market Cap | 15Cr 13Cr 12Cr 11Cr 21Cr 1.45TCr 21Cr 147.14Cr 57Cr 738.11Cr 57Cr 56Cr 2.33TCr | P/E 2024 |
-3.79x | P/E 2025 | -1.91x |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 11Cr 11Cr 9.52Cr 18Cr 1.23TCr 18Cr 124.71Cr 48Cr 625.58Cr 48Cr 47Cr 1.98TCr | EV / Sales 2024 |
0.19x | EV / Sales 2025 | 0.3x |
| Free-Float |
99.05% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Depomed Inc
| 1 day | -9.45% |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 16/06/2026 |
Punit Patel
BRD | Director/Board Member | - | 16/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -9.45% | +3.54% | - | - | 15Cr | ||
| -0.65% | -2.93% | +47.52% | +87.34% | 99TCr | ||
| -0.29% | -3.51% | +48.78% | +63.27% | 64TCr | ||
| +0.83% | +0.26% | +16.76% | +72.52% | 45TCr | ||
| -0.38% | -3.59% | +28.24% | +35.57% | 34TCr | ||
| -0.09% | -13.54% | +10.08% | +26.87% | 26TCr | ||
| -0.43% | -2.48% | -2.07% | +11.48% | 25TCr | ||
| -1.34% | -13.70% | +33.47% | +44.18% | 20TCr | ||
| -3.44% | -7.51% | -20.08% | -59.58% | 19TCr | ||
| -0.75% | -4.82% | +21.94% | +86.55% | 18TCr | ||
| Average | -1.60% | -5.76% | +20.52% | +40.91% | 38.94TCr | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.87% | +55.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12Cr 11Cr 10Cr 9.24Cr 17Cr 1.19TCr 17Cr 121.08Cr 47Cr 607.36Cr 47Cr 46Cr 1.92TCr | 12Cr 10Cr 9.68Cr 8.78Cr 16Cr 1.13TCr 17Cr 115.03Cr 44Cr 577Cr 45Cr 44Cr 1.82TCr |
| Net income | -2.16Cr -1.86Cr -1.76Cr -1.6Cr -2.99Cr -206.17Cr -3.01Cr -21Cr -8.04Cr -104.89Cr -8.1Cr -7.93Cr -331.45Cr | -3.04Cr -2.62Cr -2.48Cr -2.25Cr -4.21Cr -290.19Cr -4.24Cr -29Cr -11Cr -147.64Cr -11Cr -11Cr -466.51Cr |
| Net Debt | -5.98Cr -5.15Cr -4.88Cr -4.42Cr -8.29Cr -571.19Cr -8.34Cr -58Cr -22Cr -290.59Cr -22Cr -22Cr -918.25Cr | -2.32Cr -1.99Cr -1.89Cr -1.71Cr -3.21Cr -221.18Cr -3.23Cr -22Cr -8.63Cr -112.53Cr -8.69Cr -8.5Cr -355.58Cr |
Employees
-
Sector
Pharmaceuticals
















